P53 and Ki67 protein expression in ocular squamous cell carcinomas of dairy cattle
Authors
Abstract:
Role of the protein overexpression is very important in the pathogenesis, diagnosis and prognosis of neoplasia. Cases of overexpression of p53 and Ki67 proteins were investigated in 19 ocular squamous cell carcinomas (OSCC) in dairy cows. Microscopically, insix cases the tumors were carcinoma in situ (noninvasive carcinoma, G0), and in the remaining 13 cases the tumors were invasive carcinoma. The distribution of invasive carcinoma was as follows: G1, 1 (7.6%); G2, 1 (7.6%); G3, 3 (23.0%); G4, 8 (61.8%). Of the 19 tumors, 18 were immunoreactive for p53 (++), and 14 showed Ki67 expression (++). A significant positive correlation was found between the percentage of p53 stained nuclei and the degree of differentiation. The Ki67 index showed a significant negative correlation with the histological pattern, where the greatest proliferation was found in the most poorly differentiated OSCC. As in human squamous cell carcinoma(SCC), p53 overexpression is frequent in bovine OSCC, providing support for a possible role of the protein in the pathogenesis of this neoplasm.
similar resources
p53 and ki67 protein expression in ocular squamous cell carcinomas of dairy cattle
role of the protein overexpression is very important in the pathogenesis, diagnosis and prognosis of neoplasia. cases of overexpression of p53 and ki67 proteins were investigated in 19 ocular squamous cell carcinomas (oscc) in dairy cows. microscopically, insix cases the tumors were carcinoma in situ (noninvasive carcinoma, g0), and in the remaining 13 cases the tumors were invasive carcinoma. ...
full textExpression Of P53 And Ki67 Proteins In Renal Cell Carcinoma And Its Relationship With Nuclear Grade
Background and Objective: Evaluation of tumor proliferative activity may provide a predicting parameter to estimate biologic aggression and a subsequent prognosis that has been evaluated in many malignancies. We have selected renal cell carcinoma (RCC) in this study. To determine tumor proliferative activity, KI67 antibody was applied and results were compared with apoptosis, applying P53 antib...
full textImmunohistochemical expression of CD10 in cutaneous basal and squamous cell carcinomas
Background: Non-melanoma skin cancer is the most common malignant tumor in humans. The role of ultraviolet radiation is well-known in the pathogenesis of basal cell carcinoma (BCC) and squamous cell carcinoma (SCC). CD10 is a zinc-dependent metallopeptidase known as common acute lymphoblastic leukemia antigen (CALLA). Although CD10 expression has been investigated in some cutaneous tu...
full textValue of CD10 Expression in Differentiating Cutaneous Basal from Squamous Cell Carcinomas and Basal Cell Carcinoma from Trichoepithelioma
Background: In addition to the well-defined histological criteria for squamous cell carcinoma (SCC) and basal cell carcinoma (BCC), immunohistochemical techniques can be used in difficult cases for their differentiation. As differential diagnosis between trichoepithelioma (TE) and BCC is sometimes difficult for the clinician and the pathologist, CD10 may be a useful marker for definite diagnosi...
full textdetermination of p53 protein, ki67 antigen and c-erb-b2 expression and their correlation in well-differentiated squamous cell carcinoma (scc) of tongue
0
full textComparison of Expression of p53 and bcl-2 Markers in Oral Lichen Planus and Oral Squamous Cell Carcinoma
Background and Aim: It has been suggested that oral lichen planus (OLP) can be a potential premalignant lesion. Reports are also available on the role of bcl-2 and p53 proteins in malignant transformation of OLP into oral squamous cell carcinoma (OSCC). Due to controversies in these reports, the present study aimed to compare the expression of p53 and bcl-2 markers in OLP and OSCC. Materials a...
full textMy Resources
Journal title
volume 5 issue 4
pages 223- 226
publication date 2011-12-01
By following a journal you will be notified via email when a new issue of this journal is published.
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023